Afuco™ Anti-PCSK9 ADCC Therapeutic Antibody (Lodelcizumab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant humanized antibody expressed in CHO binding to human PCSK9. Lodelcizumab is a monoclonal antibodiess for the treatment of hypercholesterolemia.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-TAB-758 |
| Pricing | Inquiry |
| Host | Human |
| Target | PCSK9 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Applications | ELISA, FC, IP, FuncS, IF, Neut |
| Storage | Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |